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Abstract
Background: Image analysis of microarrays and, in particular, spot quantification and spot quality
control, is one of the most important steps in statistical analysis of microarray data. Recent
methods of spot quality control are still in early age of development, often leading to
underestimation of true positive microarray features and, consequently, to loss of important
biological information. Therefore, improving and standardizing the statistical approaches of spot
quality control are essential to facilitate the overall analysis of microarray data and subsequent
extraction of biological information.
Findings: We evaluated the performance of two image analysis packages MAIA and GenePix (GP)
using two complementary experimental approaches with a focus on the statistical analysis of spot
quality factors. First, we developed control microarrays with a priori known fluorescence ratios to
verify the accuracy and precision of the ratio estimation of signal intensities. Next, we developed
advanced semi-automatic protocols of spot quality evaluation in MAIA and GP and compared their
performance with available facilities of spot quantitative filtering in GP. We evaluated these
algorithms for standardised spot quality analysis in a whole-genome microarray experiment
assessing well-characterised transcriptional modifications induced by the transcription regulator
SNAI1. Using a set of RT-PCR or qRT-PCR validated microarray data, we found that the semi-
automatic protocol of spot quality control we developed with MAIA allowed recovering
approximately 13% more spots and 38% more differentially expressed genes (at FDR = 5%) than
GP with default spot filtering conditions.
Conclusion: Careful control of spot quality characteristics with advanced spot quality evaluation
can significantly increase the amount of confident and accurate data resulting in more meaningful
biological conclusions.
Published: 17 September 2008
BMC Research Notes 2008, 1:80 doi:10.1186/1756-0500-1-80
Received: 20 June 2008
Accepted: 17 September 2008
This article is available from: http://www.biomedcentral.com/1756-0500/1/80
© 2008 Friederich et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Research Notes 2008, 1:80 http://www.biomedcentral.com/1756-0500/1/80
Page 2 of 13
(page number not for citation purposes)
Background
Microarray technology allows gaining novel insights into
different biological phenotypes by studying genome-wide
differences in gene expression profiles [1,2]. Many efforts
have been made to standardize microarray data analysis
pipelines [3,4]. Several initiatives such as the MAQC
project showed that standardising data analysis proce-
dures improved performance of microarray platforms [5].
A critical component of the microarray data analysis pipe-
line is image analysis. Any error made at this stage of the
analysis may propagate throughout the pipeline invalidat-
ing final biological conclusions such as differential
expression or gene network establishment. Among the
various approaches aiming at improving microarray anal-
ysis, one of the most important and less formalized is the
evaluation of the quality of spots obtained in microarray
experiments [6]. Too stringent spot quality requirements
can result in filtering-out relevant spots and loss of useful
biological information. Conversely, too flexible filtering
conditions will conserve bad spots leading to wrong pre-
dictions. This situation is mainly observed when analys-
ing weak or contaminated spots which yet might contain
important biological information. Numerous studies are
aimed at improving the control of microarray spot quality
including spot quality assessment [7] and filtering [8],
evaluation of normalisation procedures [9], missing val-
ues imputation [10], comparison of different spot quality-
assessing algorithms [11]. However, there is still a lack of
consistent and standardized methodology for microarray
image analysis using advanced algorithms for automated
spot quality evaluation.
Several software tools, such as AMIA [12], Matarray [13],
MASQOT-GUI [14], Tiger Spotfinder [15], MAIA [16],
which are based on standardized, semi-automated strate-
gies for microarray image analysis are currently available
for academic users. GenePix Pro (Molecular Devices, Sun-
nyvale, CA, USA) is a representative commercial software
that is routinely used. Among reported software [for a
brief overview see Additional file 1] GenePix (GP) and
MAIA have distinct advantages. GP provides automated
and user-friendly tools for microarray gridding, feature
alignments, data management, and graphical representa-
tion of the results. GP has also functionality for spot qual-
ity analysis, in particular, a filter system for flagging spots
as "good" (Flag = 100) or "bad" (Flag = 0) based on a user-
defined set of conditions for the GP parameters. However,
this facility is not automated and spot qualification in GP
is highly dependent on user decisions. We have chosen
MAIA as a representative example of an automated spot
quality treatment allowing to save spots containing useful
biological information [16]. MAIA implements a compact
set of statistical algorithms for microarray image analysis,
including algorithms for the spot quality analysis at the
pixel level. MAIA assigns to each ratio estimate a quality
score ranging from 0 to 1. This score is calculated from 10
main quality characteristics reflecting different spot prop-
erties within the microarray.
Here, we developed advanced spot quality evaluation
methodologies for MAIA and GP. These approaches were
evaluated experimentally and compared to the default
parameter filtering settings provided in GP. The precision
and accuracy of spot quantification procedures were veri-
fied using microarrays with a priori known ratios of Cy5 to
Cy3 intensities and biological relevance was assessed by
comparing differentially expressed genes and significantly
over-represented gene ontology (GO) categories in a
whole-genome transcriptomic microarray experiment.
Our results show that advanced spot quality evaluation
methodologies developed in MAIA give slightly more
accurate and precise Log2 ratios of signal intensities allow-
ing to recover more useful spots and differentially
expressed genes when compared with the default spot fil-
tering procedure in GP.
Methodology for spot quality evaluation
Semi-automatic pipeline in MAIA
The main principles of the semi-automatic image analysis
in MAIA are briefly outlined [6]. The general image
processing workflow is shown in Figure 1A. In Block 1,
raw data, i.e. .tif and .gal (GenePix Array List) files, are
imported in the program, whereupon the automatic
image analysis procedure is launched: Spot Localization
(Block 2), Image Alignment (Block 3), Spot Quantification
(Block 4) and Quality Analysis (Block 5). Part of the proce-
dure presented in Figure 1A, Blocks 1–4, is also applicable
to GP. To standardize procedures for spot quality evalua-
tion in MAIA, we expand the block Quality Analysis (Block
5) into three main steps, presented in Figure 1B: semi-
automatic fitting of the quality parameter weights (Block
ii), analysis of the histograms/distributions of the quality
parameters (Block iii); and manual spot characterization
(Block iv). Semi-automatic fitting (Figure 1C) of the qual-
ity parameter weights can only be launched for an image
comprising replicated spots [6]. In Block b the initializa-
tion of the quality parameter limits is performed. The
quality parameter weights are then fitted in Block c Fit
Limits, yielding appropriate parameter limits for quality
assessment. In Block d a proper value of the Quality Limit
is defined to reach an acceptable statistical error range.
The Fit limits procedure from Block c may over- or under-
estimate limits of the quality parameters. Identifying a
sub-set of relevant quality parameters can be achieved by
analyzing their distributions (Block iii, Figure 1B), a step
which also allows refining the limits of the quality param-
eters.BMC Research Notes 2008, 1:80 http://www.biomedcentral.com/1756-0500/1/80
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Spot filtering in GP
Many microarray studies performed with GP use standard
or default settings of GP criteria and parameter limits for
filtering spot features. An example of the use of default
parameters in GP, named here standard  parameters, is
shown in Table 1[17]. However, the standard set of GP
parameters is not always optimal and may result in losing
many informative spots. To systematize GP filtering, we
The workflow diagram of the semi-automatic analysis pipeline in MAIA Figure 1
The workflow diagram of the semi-automatic analysis pipeline in MAIA. (A) Main scheme of the semi-automatic 
analysis pipeline in MAIA. (B) Scheme of the spot quality analysis using the quality parameters. (C) Scheme of the semi-auto-
matic fitting of the parameter limits.
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Table 1: The GP parameters and limits for different filtering conditions in GP. 
Filtering conditions
Parameter Strong Medium Weak Standard
1 Dia. >= 120 >= 100 >= 70 NR
2 % > B635+2SD > 98 > 95 > 66 > 55*
3 % > B532+2SD > 98 > 95 > 66 > 55
4 F635% Sat. < 1 < 5 < 10 < 2–3
5 F532% Sat. < 1 < 5 < 10 < 2–3
6 Rgn Ratio (635/532) > 0 > 0 > 0 NR
7 Rgn R2 (635/532) > 0.8 > 0.6 > 0.4 > 0.5
8 Circularity > 85 > 80 > 50 > 80
9 F635 Median – B635 > 600 > 400 > 200 NR
10 F532 Median – B532 > 600 > 400 > 200 NR
11 SNR 635 > 10 > 5 > 2 > 3
12 SNR 532 > 10 > 5 > 2 > 3
13 Flags >= 0 >= 0 >= 0 >= 0
The table summarises the main parameters and limits for different filtering conditions used in GP. Other parameters and limits that are used in 
default/standard filtering setting of GP/Acuity are: [Sum of Medians (635/532)] > 200–500, [B532 CV] < 25, [B635 CV] < 25, LCase([ID]) <> "empty". 
NR indicates that a corresponding parameter is not a default parameter as recommended in GP.BMC Research Notes 2008, 1:80 http://www.biomedcentral.com/1756-0500/1/80
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tested various sets of the GP parameters and their cutoff
values to define a set of parameters preserving a maximum
of informative spots. We analysed 56 parameters provided
by GP and classified them into nine groups, representing
logically-formalized properties of a spot in a microarray
[see Additional file 1]. These groups were established
using hierarchical clustering with the Pearson centered
metrics applied to a representative microarray. By com-
bining proper parameter representatives of each correla-
tion group with spot properties, we reduced the full set of
the GP parameters to a limited number of the most repre-
sentative parameters which were further used for auto-
matic filtering in GP. From the distributions, we defined
three groups of filtering conditions for detecting "good"
spots associated with three levels of filtering stringency
(weak, medium and strong/stringent) and corresponding to
1, 2, and 3 STD borders of the tails in the parameter dis-
tributions. List of selected GP parameters and summary of
the estimated parametric constrains are shown in Table 1.
Additionally, so-called standard configuration of default
GP parameters and filtering limits provided in the GP and
Acuity software [17] are given in Table 1 and are used in
the following analysis.
Microarray analysis pipeline
A brief overview of steps common to MAIA and GP of our
microarray analysis pipeline (normalization, preprocess-
ing, aso) are given below.
The overall flow of statistical analysis of microarray data
performed in this study is shown in Figure 2. Data
processing starts with import of the scanned microarray
image files (.tif files) and GenePix Array List file (.gal file),
in Block 1. Block 2–4 represents microarray image analy-
sis that can be performed either by MAIA or GP. Image
Analysis consists of Spot Localization (Block 2), Spot Quan-
tification (Block 3) and Spot Quality Analysis (Block 4). For
Spot Quality Analysis, the spots are further quantified
using several statistical quality factors, which are also used
in subsequent filtering (Block 5). The microarray data are
normalized (Block 6), and then series of microarray data
are combined in one dataset table (Block 7) for prelimi-
nary treatment, which includes procedures of dye-swap
transformation, evaluation and correction of genes with
missing values, data centring and scaling, data visualisa-
tions (box plots, histograms of the Log2 ratios, MA-plots).
Differential analysis of gene expression data from repli-
cated microarrays is done (Block 8), differentially
expressed genes at the accepted false-discovery rate are
identified (Block 9) and then submitted for GO mining
(Block 10). The results of GO mining are analyzed (Block
11) to identify the relative enrichment of significant func-
tional categories. The data analysis pipeline yields lists of
differentially expressed genes and significantly enriched
biological categories (Block 12). Microarray data are vali-
dated using the RT-PCR or qRT-PCR techniques applied to
a set of selected genes (Block 13).
Experimental evaluation of standardized approaches for 
spot quality assessment using control microarrays with a 
priori known fluorescence ratios
Spot quality can be evaluated in terms of i) accuracy and
precision of the obtained ratio estimates and ii) quantita-
tive characterization of various spot defects or systematic
distortions, such as dust, donut-shaped spots, smears,
outliers, saturated and high-background pixels, non-lin-
ear foreground and background signals. First, we evalu-
ated the accuracy and precision of the algorithms for ratio
estimation. For this purpose, we developed five dedicated
microarrays referred as to control chips using the Arabi-
dopsis thaliana spike RNA control set produced by the
Institute for Genomic Research [18]. The control microar-
rays actually consist of three populations of spots further
noted as down-, invariant-, and up- features [see Additional
file 2]. Spots deemed as relevant by both MAIA and GP in
all five microarray replicates were selected and the corre-
sponding means of signal intensity Log2 ratio were ana-
lysed. First, we directly compared non-normalized data of
down- and up-features immediately after spot quantifica-
tion. Then, we compared these data upon calibration to
remove any linear bias introduced by the quantification
algorithms. This transformation consisted in a linear nor-
malization of the Log2 ratios so that the set of invariant fea-
tures, i.e. features with 1:1 theoretical ratios, was centred.
A brief summary of comparison of 5 control slides is given
in Table 2 (for a full version of Table 2 see Additional file
3). The plots Log2 Ratio vs Intensity of a typical control
microarray obtained in MAIA (top) and GP (bottom) are
shown in Figure 3. Three groups of spots were found with
mean Log2 ratios corresponding to those expected, but
being more dispersed when analysed using GP. We also
noted that MAIA gives more precise estimations of the
Log2 ratios. Analysis of the relative errors showed that esti-
mations of the Log2 ratios by MAIA were on average 5–7%
closer to the expected ones as compared to those found
with GP. After calibration the difference became less sig-
nificant. A paired t-test of two samples assuming equal
variances also showed that the differences in means were
significant for the non-calibrated data. For the calibrated
data, subtle differences were observed only for down-fea-
tures. Discrepancy in the expression ratios may be due to
different quantification strategies in the two programs.
Indeed, the GP manual recommends using medians to
estimate the foreground and background fluorescence
intensities in Cy3 and Cy5 colour channels to create the
final ratio estimate. In MAIA, the mean estimates are used
instead. Although the median estimates ensure more
robust ratio values, it is known that they have larger stand-
ard deviations than means [19]. As in MAIA the mean esti-
mates are calculated after special outlier-filteringBMC Research Notes 2008, 1:80 http://www.biomedcentral.com/1756-0500/1/80
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Overall flow diagram of the statistical analysis of microarray data Figure 2
Overall flow diagram of the statistical analysis of microarray data.
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procedure [20], these estimates are robust and better pre-
serve precision of the final ratios.
Collectively, our data show that MAIA generally gives
slightly more accurate and precise Log2 ratios. An addi-
tional processing step or a proper calibration of the data is
therefore needed in GP to smooth out the differences in
Log2 ratios between the programs. This should allow con-
serving more informative spots in the follow-up analysis.
Evaluation of the performances of the image analysis 
methodologies in a comparative gene expression study 
using whole-genome arrays
Although accuracy and precision of the ratio estimates are
important for reliable follow-up analysis, the major prob-
lem in microarray studies comes from deficient spots that
when being improperly treated, may obscure the final
conclusions. However, while stringent filtering conditions
allow eliminating such bad spots, they also might lead to
the loss of good, informative spots.
Our artificial microarrays with the known ratios are of
very good overall quality and therefore they are not appro-
priate to evaluate algorithms for quantitative characteriza-
tion of various spot deficiencies or systematic distortions.
To evaluate the developed filtering procedures, we used
oligonucleotide microarrays measuring genes which are
differentially expressed in human MCF-7 epithelial breast
carcinoma cells after induction of the transcription regu-
lator SNAI1 [see Additional file 2]. SNAI1 directly
represses the expression of a set of genes triggering thereby
a well-described transcriptomic program which leads to
the transition of epithelial cells to a mesenchymal pheno-
type [21]. Because functional categories of genes that are
up- or down-regulated during this process are well-charac-
terized [22], we considered this experimental model suit-
able to further evaluate the performance of the image
analysis procedures. We used cells transfected with the
human SNAI1-cDNA cloned in a tetOff conditional
expression system. Expression profiles before and after
SNAI1 induction (time points 0 and 96 hours, a sample at
time point 0 was a reference) were analyzed using oligo-
nucleotide two-color microarrays purchased from the
"University Medical Center of Utrecht" (UMCU, The
Netherlands) [23]. The microarray images were analysed
either by MAIA or GP as described in Figure 2. We applied
the semi-automatic approach for the spot quality assess-
ment in MAIA and four filtering conditions – standard,
weak,medium, and strong (defined in the Table 1) – for the
spot quality assessment in GP. For the analysis in GP, we
arbitrarily selected one microarray out of the 9 in the
series and performed automatic gridding and spot quanti-
fication procedures. Weak, medium and strong/stringent fil-
tering conditions were defined as described in Additional
file 1 by considering 1, 2 and 3 STD borders in the distri-
butions of the GP parameters (see in Table 1). We used the
default GP filtering parameters as standard.
The average number of spots deemed as "good" using
MAIA and GP programs, calculated as a percentage of total
number of spots in a microarray (25 392), is plotted in
Figure 4. MAIA detected 13%, 19%, and 36% more
"good" spots than GP with standard, medium and strong fil-
tering conditions, respectively. Moreover, the number of
good-quality spots found with MAIA, 53%, was compara-
ble to that obtained by the GP-weak filtering, 51%. Obvi-
ously, the proportion of "good"-quality spots might be
increased technically by releasing filtering conditions
defined by cutoff values for the GP parameters. This
would lead to an increase of the number of true "good"
spots (true positives), but would also generate more false
"good" spots (false positives). We found that a majority of
Table 2: Mean Log2ratio obtained from analysis of five control slides by MAIA and GP. 
Log2 ratio Calibrated Log2 ratio
Slide Population MAIA GP MAIA GP
Slide 1 Down -1.74(0.10) -1.83(0.11) -1.47 -1.45
Up 1.26(0.08) 1.14(0.18) 1.53 1.52
Slide 2  Down -2.07(0.11) -2.19(0.13) -1.46 -1.45
Up 0.92(0.10) 0.79(0.13) 1.53 1.54
Slide 3 Down -1.33(0.13) -1.44(0.15) -1.58 -1.55
Up 1.75(0.10) 1.60(0.13) 1.50 1.50
Slide 4 Down -1.55(0.15) -1.68(0.18) -1.56 -1.54
Up 1.53(0.12) 1.35(0.17) 1.51 1.49
Slide 5 Down -1.44(0.06) -1.48(0.12) -1.43 -1.44
Up 1.49(0.04) 1.45(0.19) 1.50 1.49
The mean Log2 ratio obtained from analysis of five control slides by MAIA and GP for down- and up- notated populations of features with expected 
Log2 ratios of -1.58 and 1.58. The standard variation of the mean Log2 ratio is shown in brackets. The p-values from the paired t-test for the Log2 
ratios are less than 1.4E-3. The p-values from paired t-test for the calibrated Log2 ratios are in range [1.7E0-7; 0.72]. For the full version of Table 2, 
including p-values from the paired t-test and estimated errors for the Log2 ratio, see Additional file 3.BMC Research Notes 2008, 1:80 http://www.biomedcentral.com/1756-0500/1/80
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Log2 ratio vs Signal Intensity scatter plots obtained by MAIA (A) and GP (B) for a selected control microarray Figure 3
Log2 ratio vs Signal Intensity scatter plots obtained by MAIA (A) and GP (B) for a selected control microarray. 
The fixed number of down-, invariant-, and up- features, found "good" by both programs, is selected for the statistical compari-
son. Procedures of girding and image quantifications were done automatically as recommended in the corresponding manuals 
of MAIA and GP. A control microarray consists of three populations of spots with expected Log2 ratios of -1.58 (3:1), 0 (1:1), 
and 1.58 (1:3) [see Additional file 2]. Data yielded by the GP analysis are more dispersive. We assume that no normalisation 
procedure is required for these data even at low signal intensities, where the experimental data may deviate from the theoret-
ical values. Data are not calibrated and not normalized.
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the spots identified as "good" in MAIA but not in GP,
independent of the stringency of the filtering procedure in
GP, were associated with saturated and/or contaminated
pixels or with low signals or high background levels [see
Additional file 4]. To address the biological relevance of
these extra "good" spots found in MAIA compared to GP,
we further analyzed the differentially expressed (DE)
genes. To determine their significance level and their bio-
logical value we used the SAM and GoMiner programs,
respectively [24,25]. The SAM (Significance Analysis of
Microarrays) is a modified t-test for finding significantly
expressed genes in a set of microarray experiments. GoM-
iner, a program package, organizes lists of DE genes from
a microarray experiment for gene ontology-based biolog-
ical interpretation. This analysis provides quantitative and
statistical output on enrichment or depletion of bio-cate-
gories of DE genes.
To identify the DE genes from the "good" spot datasets
produced by MAIA and GP we applied one-class response
type of SAM. Summary of the SAM plots resulting from
the analysis of each (MAIA or GP) "good" spot dataset is
shown in Figure 5. At the cutoff FDR = 5% the MAIA spot
quality analysis preserved 12% more significant genes
than GP weak filtering conditions, 38% and 47% more
significant genes than GP standard and medium filtering
conditions and even more (85%) with more stringent GP
filtering conditions. The number of DE genes found after
medium and standard filtering was in a close range, remain-
ing at the same proportion as for deemed "good" spots.
Average number of "good" spots obtained from spot quality analysis of the whole-genome microarrays using MAIA and four fil- tering approaches in GP Figure 4
Average number of "good" spots obtained from spot quality analysis of the whole-genome microarrays using 
MAIA and four filtering approaches in GP. Series of nine whole-genome microarrays, slides containing 25 392 spots (21 
521 70-mers and 3 871 control spots, Operon, human whole genome version 2.0), were printed onto Corning UltraGAPS 
slides with 48 subgrids of 23 × 23 spots. Differential expression of genes after SNAI1 induction was analysed. Data were ana-
lysed using the semi-automatic approach for the spot quality assessment in MAIA and four filtering conditions – standard, weak, 
medium, and strong (defined in the Table 1) – for the spot quality assessment in GP resulting in two groups of spots: "good" and 
"bad". The bars show the average number of "good" spots, calculated as a mean of nine microarrays, obtained from spot quality 
analysis either by MAIA or GP. Results are expressed as percentages relative to the total number of spots in each microarray.
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The SAM plots of the nine whole-genome microarrays resulted from spot quality analysis in MAIA and GP Figure 5
The SAM plots of the nine whole-genome microarrays resulted from spot quality analysis in MAIA and GP. (A) 
Number of called genes [24] versus the false discovery rate (FDR) as resulted after SAM analysis of gene lists generated by 
MAIA and GP-associated analysis. (B) The number of differentially expressed genes (called genes) at FDR = 5 and 1% found by 
SAM.
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However, medium and standard filtering yielded about 38–
47% less DE genes than those obtained by analysis in
MAIA. In addition the GP weak filtering did not yield as
many DE genes when compared with MAIA, albeit the
input was similar, 51 and 53%, respectively. Nevertheless,
the list of the GP weak  DE genes exceeded over those
obtained from the GP standard and medium filtering con-
ditions. This is additional proof that the default filtering
parameters in GP may be sub-optimal and need to be
improved and to be automated. The GP strong filtering
gave the shortest list of DE, corresponding to 20% of the
MAIA DE gene list, and to highly-expressed genes in the
study, i.e. genes associated with high-quality spots in the
arrays.
Significant DE genes identified by SAM analysis (FDR cut-
off 5%) of all "good"-quality spots in MAIA and GP were
submitted to GoMiner to identify the over-represented
GO categories as compared to the overall GO categories
represented on the whole microarray. GO analysis high-
lighted a marked enrichment in GO categories in the gene
dataset obtained from MAIA. Indeed, 278 enriched GO
categories were identified in the dataset from MAIA, com-
pared with 179 from GP-standard, 202 from GP-weak, 204
from GP-medium, and 112 from GP-strong (p-value cutoff
5%, FDR cutoff 30%) [see Additional file 5]. Interestingly,
the GP-weak filtering did not introduce much more bio-
logical terms than the GP-standard  filtering, indicating
that lowering the spot filtering conditions in GP did not
improve gene data mining or statistical significance of the
GO categories. Analysis of the GO terms after the GP-
standard filtering revealed that the majority of functional
categories were similar to those obtained by MAIA
although leading to higher p-values and FDR scores [see
Additional file 5]. When considering GO categories
potentially playing an important role in SNAI1 activity
and EMT process, p-values of the Fisher exact test resulting
from the GoMiner analysis were slightly lower with MAIA
dataset than those obtained with GP (Table 3). Among the
GO categories listed in Table 3, some were most impor-
tant bio-functions involved in the EMT processes. For
example, the categories regulation of cell cycle and  cell
growth indicated a direct blocking of these functions, after
the ectopic expression of the SNAI1 protein [26]. Wnt-
pathway is known to contribute to the EMT [27] and Vita-
min D receptor has been shown recently to be directly reg-
ulated by the SNAI1  protein [28]. Finally, ectopic
expression of SNAI1 target genes is involved in the estab-
lishment of cytoskeleton organization [29]. Our results
suggested that the larger number of significant DE genes
obtained in MAIA is related to the net increase in enriched
GO categories. This could be very helpful when analysing
the contribution of groups of genes in specific biological
processes.
To compare various spot quality evaluation approaches
using MAIA and GP, we established a list of bone fide DE
genes. To do so, we first randomly selected about a hun-
dred genes based on their differential expression behav-
iour and their confirmed or potential function in EMT, as
supported by literature search. This approach enabled us
enriching the list for "true" DE genes. Out of this first list,
we randomly selected 24 genes the differential expression
of which was confirmed by the RT-PCR and qRT-PCR
(Table 4). Then, we determined how many of these 24
confirmed genes were detected by various spot quality
evaluation approaches. Summary of this comparison,
including genes annotation and description, is presented
in Table 4. 14 genes were detected using the GP-standard
conditions, 17, 9, 2 were included in the GP-weak, GP-
medium, GP-strong  lists, respectively. All 24 genes were
found in the MAIA DE gene list.
Conclusion
Altogether, our data indicate that MAIA is a robust micro-
array image analysis program allowing a more accurate
spot quantification and an improved collection of signifi-
cant and relevant DE genes compared to GP. When con-
Table 3: p-values of selected GO categories resulted from the different conditions of analysis. 
GO term MAIA GP-standard GP-weak GP-medium GP-strong
Kinase activity 0.000 0.002 0.000 0.088 0.849
Regulation of cell cycle 0.001 0.039 0.014 0.013 0.201
Hormone receptor binding 0.006 0.006 0.073 0.093 0.307
Wnt receptor activity 0.016 0.732 0.053 0.258 1.000
Actin cytoskeleton 0.063 0.088 0.134 0.164 0.102
Transcriptional repressor activity 0.003 0.007 0.000 0.017 0.029
Transcriptional activator activity 0.026 0.352 0.177 0.685 0.439
Vitamin D receptor binding 0.005 0.003 0.013 0.041 1.000
Regulation of cell growth 0.066 0.094 0.016 0.022 0.868
Several biological categories with a well-established role in epithelial to mesenchymal transition (EMT) were selected for comparison in terms of the 
p-values. p-values obtained for the GP-strong gene list have the weakest statistical meaning. Statistical results yielded from GP-standard, weak, and 
medium filtering are in mutual agreement. MAIA gave the best p-values among all tested spot quality approaches. Presented categories were 
obtained with FDR < 0.3. BMC Research Notes 2008, 1:80 http://www.biomedcentral.com/1756-0500/1/80
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sidering GO categories potentially playing an important
role in SNAI1 activity and EMT process, statistically
enriched categories obtained by a GoMiner analysis had
slightly lower p-values with MAIA dataset than those
obtained with GP. Due to a larger number of significant
DE genes, MAIA ensures a net increase in enriched GO cat-
egories. This could be very helpful when looking for sub-
tle contribution of some biological processes. More
generally, this study showed that careful control of spot
quality characteristics with advanced spot quality evalua-
tion can significantly increase the amount of meaningful
data yielding more confident and accurate biological con-
clusions.
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Table 4: Comparison of MAIA and GP spot filtering approaches on a set of 24 selected genes confirmed by RT-PCR or qRT-PCR. 
Symbol Description MAIA GP-standard GP-weak GP-medium GP-strong
Down
KLF5 Krueppel-like factor 5 + + + +
TJP3 Tight junction protein ZO-3 + + +
KRT12 Keratin, type I cytoskeletal 12 + + +
BSPRY B-box and SPRY domain containing + +
CORO1A Coronin-1A + + + +
STAP2_HUMAN Signal-transducing adaptor protein 2 + +
PPP1R16A Protein phosphatase 1 regulatory subunit 16A + + + + +
KRT18 Keratin, type I cytoskeletal 18 +
STMN3 Stathmin-3 + + + +
TRIB3 Tribbles homolog 3 + +
CLDN3 Claudin-3 +
TXNIP Thioredoxin interacting protein +
Up
MSX1 Homeobox protein MSX-1 + + + +
GULP1 GULP, engulfment adaptor PTB domain containing 1 + + + +
DUSP2 Dual specificity protein phosphatase 2 + + + +
ID3 DNA-binding protein inhibitor ID-3 +
THBD Thrombomodulin precursor + + +
HS6ST2 Heparan sulfate 6-O-sulfotransferase 2 + + +
TGFBI Transforming growth factor-beta-induced protein ig-h3 
precursor
+
S100A10 Calpactin I light chain +
SERPINH1 Collagen-binding protein 2 precursor +
SNAI2 Zinc finger protein SLUG + + +
COL5A1 Collagen alpha 1(V) chain precursor + + + +
ANXA2 Annexin A2 + + + + +
RT-PCR and qRT-PCR analysis of 24 selected genes was performed to validate microarray data. Then, the presence of these genes in lists of DE 
genes obtained in the whole-genome microarray experiment was determined using different spot quality evaluation approaches in MAIA and GP. 
Fourteen genes were detected using the GP-standard conditions, 17, 9, 2 were present in the GP-weak, GP-medium, GP-strong lists, 
correspondingly. All 24 genes were found in the MAIA DE gene list. The sign "+" indicates if a gene is present in the corresponding DE gene list.BMC Research Notes 2008, 1:80 http://www.biomedcentral.com/1756-0500/1/80
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